These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21504357)

  • 1. Olanzapine-induced agranulocytosis in an adolescent male with psychosis.
    Freedman JL; Ryan CA; Coffey BJ
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):185-9. PubMed ID: 21504357
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine-induced agranulocytosis in systemic lupus erythematosus: a case report.
    Su JA; Wu CH; Tsang HY
    Gen Hosp Psychiatry; 2007; 29(1):75-7. PubMed ID: 17189752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early withdrawal in a double-blind randomized clinical trial with olanzapine and risperidone performed in adolescents with first psychosis.
    van Nimwegen L; de Haan L
    Psychopathology; 2006; 39(3):158. PubMed ID: 16531692
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
    van Nimwegen-Campailla L; van Beveren N; Laan W; van den Brink W; Linszen D; de Haan L
    Pharmacopsychiatry; 2010 Nov; 43(7):281. PubMed ID: 20839158
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
    Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
    J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin rash occurring with olanzapine pamoate, but not with oral olanzapine, in a male with juvenile idiopathic arthritis.
    Solfanelli A; Curto M; Dimitri-Valente G; Kotzalidis GD; Gasperoni C; Sani G; Manfredi G; Rapinesi C; Comparelli A; Girardi P
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):232-4. PubMed ID: 23607414
    [No Abstract]   [Full Text] [Related]  

  • 8. Blepharospasm associated with olanzapine: a case report.
    Shimizu E; Otsuka A; Hashimoto K; Iyo M
    Eur Psychiatry; 2004 Sep; 19(6):389. PubMed ID: 15363484
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of akathisia after switching from branded to generic high-dose olanzapine.
    Goldberg JF
    J Clin Psychiatry; 2012 Apr; 73(4):497. PubMed ID: 22579148
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 11. Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?
    Suzuki T; Takeuchi H; Watanabe K
    J Clin Psychiatry; 2010 Nov; 71(11):1553-4; author reply 1554. PubMed ID: 21114953
    [No Abstract]   [Full Text] [Related]  

  • 12. [Edema related to treatment with olanzapine].
    Wustmann T; Fiedler T; Gutmann P
    Psychiatr Prax; 2009 Apr; 36(3):142-4. PubMed ID: 18504690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia.
    Stip E; Langlois R; Thuot C; Mancini-Marïe A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):297-300. PubMed ID: 16978752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-induced chylomicronemia presenting as acute pancreatitis.
    Rossor AM; Leech N; Neely RD
    J Clin Psychopharmacol; 2007 Aug; 27(4):395-6. PubMed ID: 17632226
    [No Abstract]   [Full Text] [Related]  

  • 16. Authors' response to comments regarding risperidone versus olanzapine Markov model.
    Value Health; 2005; 8(5):613-4. PubMed ID: 16176499
    [No Abstract]   [Full Text] [Related]  

  • 17. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
    Kunz M; Gomes FA; Tramontina JF; Kapczinski F
    J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of psychosis subsequent to phenothiazine-induced agranulocytosis.
    Ananth JV; Beszterczey A
    Compr Psychiatry; 1973; 14(4):319-23. PubMed ID: 4146801
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.